Moderna’s shares moved sharply in after hours trading, according to market data that showed a last price of 125.37, an increase of 62.41 or 99.13 percent from the regular session close of 62.96.
The regular session closed at 62.96, down 1.50 or 2.33 percent. The snapshot lists a 52 week range between 22.28 and 85.60 and a 10 day average volume of 5.78 million shares.
Market listings show the company’s market capitalization at 25.136 billion and shares outstanding at 399.24 million. The profile records a beta of 0.92 and no dividend or yield in the summary data.
Company information on the profile highlights an approval item described as FDA approves Moderna mRNA flu shot and references a related video. The listing also notes events and profitability links under its “Show Ratios” entry.
Corporate leadership appears on the company record with Noubar Afeyan named as independent chairman and co founder, and Stephane Bancel listed as chief executive officer and director. The profile also names Stephen Hoge as president, Jerh Collins as chief technical operations and quality officer, James Mock as chief financial officer, and Rose Loughlin as executive vice president research.
The company address on file is 325 Binney Street, Cambridge MA, United States. The market snapshot shows fields for open, day high and day low recorded as 0.00 in this view.
Market Context And Investor Information
mrna stock jumped in after hours trading with price rising to 125.37, according to market data. That sentence reflects the same market snapshot that captured the intraday close and the after hours quote.
Investors referencing the snapshot will note the absence of a listed dividend and the presence of a recent regulatory milestone in the profile. Trading activity context is limited to the displayed 10 day average volume and the quoted after hours move.
The company profile groups key governance and operational figures alongside contact details and links to events and media. The public listing provides a compact set of metrics for readers but does not include additional commentary or analyst reaction in this snapshot.
